BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23459497)

  • 1. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
    Kawai Y; Miyashita N; Kubo M; Akaike H; Kato A; Nishizawa Y; Saito A; Kondo E; Teranishi H; Ogita S; Tanaka T; Kawasaki K; Nakano T; Terada K; Ouchi K
    Antimicrob Agents Chemother; 2013 May; 57(5):2252-8. PubMed ID: 23459497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
    PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
    Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
    Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S
    Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.
    Katsushima Y; Katsushima F; Suzuki Y; Seto J; Mizuta K; Nishimura H; Matsuzaki Y
    Pediatr Int; 2015 Apr; 57(2):247-52. PubMed ID: 25265270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.
    Zhou Y; Zhang Y; Sheng Y; Zhang L; Shen Z; Chen Z
    Antimicrob Agents Chemother; 2014; 58(2):1034-8. PubMed ID: 24277047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
    Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
    Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
    BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.
    Dumke R; Stolz S; Jacobs E; Juretzek T
    Int J Infect Dis; 2014 Dec; 29():197-9. PubMed ID: 25449256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.
    Hong KB; Choi EH; Lee HJ; Lee SY; Cho EY; Choi JH; Kang HM; Lee J; Ahn YM; Kang YH; Lee JH
    Emerg Infect Dis; 2013 Aug; 19(8):1281-4. PubMed ID: 23876792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
    Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
    Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.
    Ma Z; Zheng Y; Deng J; Ma X; Liu H
    Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
    Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
    BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.
    Averbuch D; Hidalgo-Grass C; Moses AE; Engelhard D; Nir-Paz R
    Emerg Infect Dis; 2011 Jun; 17(6):1079-82. PubMed ID: 21749775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Chen Y; Tian WM; Chen Q; Zhao HY; Huang P; Lin ZQ; Chen L
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Aug; 20(8):629-634. PubMed ID: 30111471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.
    Wu HM; Wong KS; Huang YC; Lai SH; Tsao KC; Lin YJ; Lin TY
    J Infect Chemother; 2013 Aug; 19(4):782-6. PubMed ID: 23196653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
    Lung DC; Chan YH; Kwong L; Que TL
    Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.